Showing 1 - 5 results of 5 for search 'Omar A. Almohammed', query time: 0.02s Refine Results
  1. 1
    Evaluating the risk of acute kidney injury and mortality associated with concomitant use of vancomycin with piperacillin/tazobactam or meropenem in critically ill and non-critically ill patients: a systematic review and meta-analysis

    Evaluating the risk of acute kidney injury and mortality associated with concomitant use of vancomycin with piperacillin/tazobactam or meropenem in critically ill and non-criticall... by Abdulmajeed M. Alshehri, Majed S. Al Yami, Atheer Aldairem, Lama Alfehaid, Abdulaali R. Almutairi, Omar A. Almohammed, Amal Mohammad Badawoud

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis

    Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis by Abdulaali R Almutairi, Renad M Altoukhi, Reema A Alshouimi, Shahad M Al Rammah, Mohammed Y Alzahrani, Abdulmajeed M Alshehri, Osamah M Alfayez, Majed S Al Yami, Omar A Almohammed

    Published 2020-09-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The effect of renal function on the clinical outcomes and management of patients hospitalized with hyperglycemic crises

    The effect of renal function on the clinical outcomes and management of patients hospitalized with hyperglycemic crises by Sumaya N. Almohareb, Sumaya N. Almohareb, Sumaya N. Almohareb, Norah Aljammaz, Nada Yousif, Mayar Sunbul, Raghad Alsemary, Lama Alkhathran, Mohammed Aldhaeefi, Omar A. Almohammed, Abdulrahman I. Alshaya, Abdulrahman I. Alshaya, Abdulrahman I. Alshaya

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia

    Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia by Abdulaali R. Almutairi PhD, Yazed Alruthia PhD, Majed S. Alyami PharmD, Omar A. Alshaya PharmD, Taif Z. Alanazi PharmD, Sarah I. Al Daghreer PharmD, Ghazwa B. Korayem PharmD, Sarah A. Alrasheed PharmD, Reema A. Alorf PharmD, Omar A. Almohammed PhD

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Clinical Characteristics and Outcomes of Deep Vein Thrombosis in Relation to Location: A Retrospective Analysis Study

    Clinical Characteristics and Outcomes of Deep Vein Thrombosis in Relation to Location: A Retrospective Analysis Study by Majed S. Al Yami PharmD, Abdulmajeed M. Alshehri PharmD, Ghadah M. Alotaibi PharmD, Mariam S. Alsulimani PharmD, Fay M. Alotaibi PharmD, Rawan A. Alotaibi PharmD, Nouf A. Alqahtani PharmD, Lama A. Alhumaidan PharmD, Lubna S. Bin Hadhir PharmD, Norah M. Alebrah PharmD, Sumaya N. Almohareb PharmD, Omar A. Alshaya PharmD, Omar S. Alkhezi PharmD, Osamah M. Alfayez PharmD, Omar A. Almohammed PhD, Amal M. Badawoud PhD

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: